SUTRO BIOPHARMA, INC.
STRO
DELAYED 1 MONTH

15 insider filings · Latest: Jun 5, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 9 8:24 PMJon Marc WiggintonDirector
Grant/Award
10,000$26.0910,000(D)

View →

Jun 5, 2026Jun 9 8:23 PMDaniel H PetreeDirector
Grant/Award
10,000$26.0910,000(D)

View →

Jun 5, 2026Jun 9 8:21 PMJames P PanekDirector
Grant/Award
10,000$26.0910,000(D)

View →

Jun 5, 2026Jun 9 8:19 PMJoseph M LobackiDirector
Grant/Award
10,000$26.0910,000(D)

View →

Jun 5, 2026Jun 9 8:18 PMSukhi JagpalDirector
Grant/Award
10,000$26.0910,000(D)

View →

Jun 5, 2026Jun 9 8:16 PMHeidi HunterDirector
Grant/Award
10,000$26.0910,000(D)

View →

Jun 5, 2026Jun 9 8:14 PMMichael DybbsDirector
Grant/Award
10,000$26.0910,000(D)

View →

Jun 5, 2026Jun 9 8:12 PMConnie MatsuiDirector
Grant/Award
10,000$26.0910,000(D)

View →

Jun 2, 2026Jun 2 8:16 PMGregory K. ChowCFO
Option Exercise
2,500—7,500(D)

View →

Mar 4, 2026Mar 6 9:25 PMDavid PaulingChief Admin. Ofcr. & GC
Option Exercise
675—0(D)

View →

Mar 4, 2026Mar 6 9:21 PMJane ChungDirector, Chief Executive Officer
Option Exercise
788—0(D)

View →

Mar 2, 2026Mar 3 11:59 PMDavid PaulingChief Admin. Ofcr. & GC
Grant/Award
37,800$20.5533,600(D)

View →

Mar 2, 2026Mar 3 11:59 PMDavid PaulingChief Admin. Ofcr. & GC
Option Exercise
2,356—7,069(D)

View →

Mar 1, 2026Mar 3 11:59 PMDavid PaulingChief Admin. Ofcr. & GC
Option Exercise
1,342—1,686(D)

View →

Mar 2, 2026Mar 3 11:56 PMHans-Peter GerberCHIEF SCIENTIFIC OFFICER
Grant/Award
45,000$20.5540,000(D)

View →

Mar 2, 2026Mar 3 11:56 PMHans-Peter GerberCHIEF SCIENTIFIC OFFICER
Option Exercise
2,843—8,532(D)

View →

Mar 1, 2026Mar 3 11:56 PMHans-Peter GerberCHIEF SCIENTIFIC OFFICER
Option Exercise
1,125—2,250(D)

View →

Mar 2, 2026Mar 3 11:51 PMGregory K. ChowCFO
Grant/Award
45,000$20.555,000(D)

View →

Mar 2, 2026Mar 3 11:48 PMJane ChungDirector, Chief Executive Officer
Grant/Award
215,000$20.55175,000(D)

View →

Mar 2, 2026Mar 3 11:48 PMJane ChungDirector, Chief Executive Officer
Option Exercise
7,750—23,250(D)

View →

Page 1 of 2

Next →